In sum, we have shown here for the first time that sGCβ1 subunit decreased tumor cell viability and migratory capability by targeting two critical points such as EMT and Akt pathway, leading to a less aggressive tumor phenotype in endometrial and cervical cancer cells (Fig. 6). This evidence concerns the gene AKT1 and neoplasm.